As the number of speakers opting for virtual presentation has increased tremendously in the last few weeks as many institutions not encouraging its staff to travel.
To avoid disappointment with a smaller number of in-person participation to the attendees joining the meeting at Radisson Baltimore Hotel and the responses collected from speakers regarding their willingness to present online, the organizers of the conference have decided to hold the meeting in virtual format.
Please write to us at vaccines@uniscigroup.org and call at 469-854-2280 for more information on the program.
6th International Conference on

VaccinesResearch & Development

Program Register

Speakers

Kathleen Maletic Neuzil, MD, MPH, FIDSA

Director, Center for Vaccine Development and Global Health, UMSOM

Philip R. Dormitzer, M.D., Ph.D.

Vice President and Chief Scientific Officer, Viral Vaccines, Pfizer

Dan H. Barouch, M.D., Ph.D.

Director, Center for Virology and Vaccine Research, BIDMC

Julie A. Ake, M.D.

Director, US Military HIV Research Program

Pei-Yong Shi, Ph.D.

John Sealy Distinguished Chair in Innovations in Molecular Biology UTMB at Galveston

Derek T. O' Hagan, Ph.D.

Senior Advisor Vaccines R&D, GSK

Marcus A. Horwitz, M.D.

Professor, UCLA School of Medicine

Nathaniel R. Landau, Ph.D.

Professor, Department of Microbiology, NYU Grossman School of Medicine

Andrea Carfi, Ph.D.

VP & Head of Research, Infectious Disease, Moderna Inc.

Vaccines R&D Previous Events

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Rino Rappuoli,
Chief Scientist & Head of External Research and Development, GSK Vaccines

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Nathalie Garçon,
Chief Executive and Scientific Officer, IRT BIOASTER

What Speakers Say

It was really a great meeting this year, with an impressive roster of speakers the day I attended.

Jay A. Berzofsky,
Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

What Speakers Say

Congratulations. You have really made progress, and the meeting is getting better each time

Stephen L. Hoffman,
Chief Executive and Scientific Officer, Sanaria Inc.

What Speakers Say

Thank you, I learned much at this meeting and made many new contacts

Michael G. Hanna,
Founder and Chairman Emeritus, Vaccinogen Inc.

What Speakers Say

The meeting is getting better every year. Great work in organizing the speaker line

Farshad Guirakhoo,
Chief Scientific Officer, GeoVax, Inc.

What Speakers Say

The first one was pretty bad but they have gotten progressively better. I thought Vaccine R&D2018 in Baltimore was well worth attending

Andrew Lees,
Scientific Director, Owner, Fina BioSolutions LLC

/

Sponsors & Exhibitors

2014

Year of Foundation

765

Speakers

2500+

Attendees

150

Happy Clients